Skip to main content

Royal Philips to acquire Malvern medical device developer BioTelemetry for $2.8B

The $72 per share offer price represents a 16.5% premium to BioTelemetry’s Dec. 17 closing price.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.